Tenon Medical Pays 125,000 Warrants to Unlock ATM Increase

summarizeSummary

Tenon Medical secured waivers from its investor and placement agent to increase its existing at-the-market offering, paying Armistice Capital with a new 125,000-share warrant at $5.02. For a cash-strapped company, the move unlocks more equity sales at the cost of added dilution.

check_boxKey Events · Financing and Capital Events · TNON

• Waivers Unlock ATM Increase

  Armistice Capital and placement agent WallachBeth waived contractual restrictions, allowing Tenon to file prospectus supplements that increase the amount sellable under its existing at-the-market program.

• 125,000 Warrants Paid as Consideration

  As consideration, Tenon issued a Series B warrant for 125,000 shares at a $5.02 exercise price, expiring September 14, 2031, with a 4.99% beneficial ownership cap.

• Standstill Extended 15 Days

  The Section 4.12(a) restriction period now runs 75 days following the Effective Date instead of 60.

• Resale Registration Required

  Tenon must file an S-3 covering the New Warrant Shares within 60 days and use commercially reasonable efforts to make it effective within 90 days (120 on full SEC review).

auto_awesomeAnalysis · TNON · Industrial Applications And Services

Tenon needed Armistice Capital's permission to sell more stock through its existing at-the-market program, and it paid for that permission with a new warrant for 125,000 shares struck at $5.02 — more than double today's $2.23 price, so the warrant is far out of the money and its near-term dilution is limited. What the waiver enables is the real story: the company can now expand the ATM it set up in August, which matters because the last 10-Q flagged going-concern doubt and less than 12 months of cash. Selling more shares into the market raises needed capital but adds dilution overhang for existing holders. The strings attached are the 15-day extension of the standstill and the 60/90-day resale registration obligation.